SWA
XERS icon

SOA Wealth Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

SOA Wealth Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-118
Closed -$261 – 922
2024
Q1 		$261 Hold
118
– – ﹤0.01% 843
2023
Q4 		$277 Hold
118
– – ﹤0.01% 831
2023
Q3 		$219 Hold
118
– – ﹤0.01% 873
2023
Q2 		$309 Hold
118
– – ﹤0.01% 857
2023
Q1 		$192 Hold
118
– – ﹤0.01% 908
2022
Q4 		$157 Hold
118
– – ﹤0.01% 917
2022
Q3 		$0 Hold
118
– – ﹤0.01% 1009
2022
Q2 		$0 Hold
118
– – ﹤0.01% 1053
2022
Q1 		$0 Buy
+118
New +$288 ﹤0.01% 1022

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

SOA Wealth Advisors's XERS Position: Q2 2024 in Review

SOA Wealth Advisors sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 118 shares — an estimated $261 sold.

SOA Wealth Advisors first reported a position in XERS in Q1 2022 and held it in 9 quarters. The position peaked at $309 in Q2 2023. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

  • SOA Wealth Advisors reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
  • SOA Wealth Advisors sold 118 Xeris Biopharma Holdings shares in Q2 2024, an estimated $261.
  • SOA Wealth Advisors first reported a position in Xeris Biopharma Holdings in Q1 2022 and held it in 9 quarters.
  • SOA Wealth Advisors's Xeris Biopharma Holdings position peaked at $309 in Q2 2023.
  • 134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on SOA Wealth Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.